Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Hepatitis

Free Subscription 23.03.2026 1 Clin Infect Dis 1 Gastroenterol Hepatol 2 Hepatology 2 J Hepatol 1 J Infect Dis 3 J Med Virol 6 J Viral Hepat 2 Minerva Gastroenterol (Torino) 2 PLoS One 1 PLoS Pathog 2 Vaccine 1 Virology

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Clin Infect Dis

1. DENYER RV, Tate JP, Benator DA, Lim JK, et al
   Hepatitis B Reactivation in a US Cohort of People With Human Immunodeficiency Virus and Hepatitis B Core Antibody After Switch to Antiretroviral Therapy Without Hepatitis B Activity.
   Clin Infect Dis. 2026 Feb 24:ciag001. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Gastroenterol Hepatol

2. LENS S, Garcia F, Mascort J, Casado M, et al
   Consensus document on the diagnosis, management, and treatment of chronic hepatitis B virus and hepatitis D virus infection in Spain.
   Gastroenterol Hepatol. 2026 Mar 11:502717. doi: 10.1016/j.gastrohep.2026.502717.
   PubMed         Abstract available
   
   

   
   Hepatology

3. TORNAI D, Mitchell MC, McClain CJ, Dasarathy S, et al
   Longitudinal assessment of circulating cytokine profile of severe alcohol-associated hepatitis.
   Hepatology. 2026 Mar 13. doi: 10.1097/HEP.0000000000001743.
   PubMed         Abstract available
   
   
4. PUTIGNANO A, Kelkar NS, Lakhloufi D, Sharma S, et al
   Antibody response to microbiota antigens is associated with alcohol-related liver disease severity and predicts mortality.
   Hepatology. 2026;83:838-850.
   PubMed         Abstract available
   
   

   
   J Hepatol

5. SONNEVELD MJ, Janssen HLA
   Is Partial Cure a Realistic Endpoint for Novel Hepatitis B Therapy? Reply to Chan et al.
   J Hepatol. 2026 Mar 11:S0168-8278(26)00134-0. doi: 10.1016/j.jhep.2026.
   PubMed        
   
   
6. SONNEVELD MJ, Janssen HLA
   Individualising endpoints in chronic HBV treatment: HBsAg loss and beyond.
   J Hepatol. 2026;84:823-828.
   PubMed         Abstract available
   
   

   
   J Infect Dis

7. MANI M, Clipman SJ, Bailey JR, Sterling RK, et al
   Single-cell hepatitis B sequencing reveals distinct viral infection events consistent with superinfection.
   J Infect Dis. 2026 Mar 20:jiag181. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   J Med Virol

8. PAMARTHI J, Panneerselvam S, Rajesh NA, Kumar JS, et al
   Pregenomic RNA as a Marker for Monitoring Disease Prognosis and Viral Relapse in Hepatitis B Patients on Long-Term Antiviral Therapy: A Systematic Review and Meta-Analysis.
   J Med Virol. 2026;98:e70866.
   PubMed         Abstract available
   
   
9. ZHANG X, Han J, Hu Q, Zhang Y, et al
   3D Radiomics Analysis Based on Liver CT Imaging for Predicting Hepatic Encephalopathy in HBV-ACLF Patients.
   J Med Virol. 2026;98:e70871.
   PubMed         Abstract available
   
   
10. SHIUE SJ, Ho TH, Lin HY, Cheng SW, et al
    Impact of Metabolic Associated Steatotic Liver Disease on Antiviral Therapy Outcomes on Chronic Hepatitis B Patients Receiving Antiviral Therapy.
    J Med Virol. 2026;98:e70864.
    PubMed         Abstract available
    
    

    
    J Viral Hepat

11. WANG DH, Wang JL, Jiang SW, Zhou AW, et al
    HBV RNA Predicts the Risk of Off-Treatment Relapse in Chronic Hepatitis B Patients With NAs Therapy: A Systematic Review and Meta-Analysis.
    J Viral Hepat. 2026;33:e70167.
    PubMed         Abstract available
    
    
12. CAVIGLIA GP, Stroffolini T
    Changing Pattern of HDV Infection in Italy Over 40 Years; the Current Scenario and the Impending Challenge.
    J Viral Hepat. 2026;33:e70172.
    PubMed         Abstract available
    
    
13. HARRISON R, Patel S, Marra F, Francisco A, et al
    Co-Administration of Hepatitis C Direct-Acting Antivirals and Enzyme-Inducing Antiepileptic Drugs: Real-World Experience From a Multi-Centre Case Series.
    J Viral Hepat. 2026;33:e70168.
    PubMed         Abstract available
    
    
14. THAKUR HS, Yadav V
    Methodological Considerations in Prevalence Meta-Analysis of Hepatitis B Among Migrants.
    J Viral Hepat. 2026;33:e70171.
    PubMed        
    
    
15. THOMPSON K, Thompson J, Miller LS
    Characteristics of Patients and Factors Associated With the Development of Hepatitis C Virus-Associated Hepatocellular Carcinoma in an Urban, Primary-Care Based Hepatitis C Clinic.
    J Viral Hepat. 2026;33:e70169.
    PubMed         Abstract available
    
    
16. GUO L, Wu W, Zhou W, Liang R, et al
    Exploration of a Model for Elimination of Hepatitis C in Women of Childbearing Age in Primary Hospitals in Southern China.
    J Viral Hepat. 2026;33:e70153.
    PubMed         Abstract available
    
    

    
    Minerva Gastroenterol (Torino)

17. KARABAY O, Kabukcu S, Guclu E, Zerdali E, et al
    Investigation of the effects of antivirals used in hepatitis B treatment on blood lipid profile: a retrospective real-life data analysis.
    Minerva Gastroenterol (Torino). 2026 Mar 18. doi: 10.23736/S2724-5985.26.03992.
    PubMed         Abstract available
    
    
18. BATTISTELLA S, LE Piane F, Galante A, Coppola C, et al
    Evaluation of Italian clinical practice for preventing HBV recurrence post-LT: a Delphi panel study.
    Minerva Gastroenterol (Torino). 2026;72:25-36.
    PubMed         Abstract available
    
    

    
    PLoS One

19. 
    Expression of Concern: Seroepidemiology and associated risk factors of hepatitis B and C virus infections among pregnant women attending maternity wards at two hospitals in Swabi, Khyber Pakhtunkhwa, Pakistan.
    PLoS One. 2026;21:e0345147.
    PubMed        
    
    
20. KELLY SE, Ajidahun A, Bytelaar S, Ding E, et al
    Beyond direct-acting antiviral therapy: Characterizing mental health conditions and depressive symptoms among patients recently treated for hepatitis C.
    PLoS One. 2026;21:e0344862.
    PubMed         Abstract available
    
    

    
    PLoS Pathog

21. ZHANG H, Wu Y, Wang H, Liu T, et al
    Experimental hepatitis E virus genotype 1 infection in three types of wild rodents.
    PLoS Pathog. 2026;22:e1014050.
    PubMed         Abstract available
    
    

    
    Vaccine

22. LOEHR J, Moser CA, Asturias EJ, Shaw AC, et al
    Science for vaccine policy: Lack of transparency, misinformation, and poor decision processes at the December 2025 ACIP meeting.
    Vaccine. 2026;76:128338.
    PubMed         Abstract available
    
    
23. TROCCOLI CS, Nascimento PS, Villar LM, Miguel JC, et al
    Long-term persistence of Seroprotection following a modified hepatitis B vaccine schedule in people living with HIV.
    Vaccine. 2026;79:128483.
    PubMed         Abstract available
    
    

    
    Virology

24. VITIELLO A, Boccellino M, Polito G, Zovi A, et al
    Hepatitis D Infection: a puzzle still unsolved?
    Virology. 2026;619:110879.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum